Nothing Special   »   [go: up one dir, main page]

GR900100786A - Μέ?οδος παρασκευής μιας συν?έσεως η οποία να περιλαμβάνει ένα αναλγητικό με συνδιασμό με ένα παρεμποδιστή του Η1 ή Η2 ένα παρεμποδιστή αντλίας πρωτονίων ή ένα συνδυασμό αυτών. - Google Patents

Μέ?οδος παρασκευής μιας συν?έσεως η οποία να περιλαμβάνει ένα αναλγητικό με συνδιασμό με ένα παρεμποδιστή του Η1 ή Η2 ένα παρεμποδιστή αντλίας πρωτονίων ή ένα συνδυασμό αυτών.

Info

Publication number
GR900100786A
GR900100786A GR900100786A GR900100786A GR900100786A GR 900100786 A GR900100786 A GR 900100786A GR 900100786 A GR900100786 A GR 900100786A GR 900100786 A GR900100786 A GR 900100786A GR 900100786 A GR900100786 A GR 900100786A
Authority
GR
Greece
Prior art keywords
combination
analgesic
ihibitor
proto
composition
Prior art date
Application number
GR900100786A
Other languages
English (en)
Other versions
GR1002097B (en
Inventor
Thomas N Gates
William J Goldman
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23709269&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR900100786(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of GR900100786A publication Critical patent/GR900100786A/el
Publication of GR1002097B publication Critical patent/GR1002097B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)

Abstract

Η εφεύρεσις αυτή αφορά μια φαρμακευτική σύνθεση δια την αγωγή συμπτωμάτων υπερβολικής μέθης που περιλαμβάνει μια αναλγητικά αποτελεσματική ποσότητα ακεταμινοφαίνης ή ενός μη στερεοειδικούς αντιφλογιστικούς φαρμάκου και μια αποτελεσματική για την παρεμπόδιση των γαστρικών οξέων ποσότητα, ενός δεσμευτού H1 ή Η2, ενός παρεμποδιστού αντλίας πρωτονίων, ή ενός συνδυασμού αυτών και μεθόδους δια την αγωγή συμπτωμάτων υπερβολικής μέθης που περιλαμβάνουν χορήγηση τέτοιων φαρμακευτικών συνθέσεων. ω
GR900100786A 1989-11-02 1990-11-01 A process for providing a composition an analgesic in combination with a h1 or h2 receptor blocker proto n pump ihibitor or combination thereof GR1002097B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43083789A 1989-11-02 1989-11-02

Publications (2)

Publication Number Publication Date
GR900100786A true GR900100786A (el) 1992-04-17
GR1002097B GR1002097B (en) 1995-12-28

Family

ID=23709269

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100786A GR1002097B (en) 1989-11-02 1990-11-01 A process for providing a composition an analgesic in combination with a h1 or h2 receptor blocker proto n pump ihibitor or combination thereof

Country Status (14)

Country Link
EP (1) EP0426479B1 (el)
JP (1) JPH03206052A (el)
KR (1) KR910009254A (el)
AT (1) ATE101515T1 (el)
AU (1) AU646230B2 (el)
CA (1) CA2028746C (el)
DE (1) DE69006684T2 (el)
ES (1) ES2057439T3 (el)
GR (1) GR1002097B (el)
IE (1) IE64953B1 (el)
IN (1) IN171746B (el)
NZ (1) NZ235877A (el)
PT (1) PT95753A (el)
ZA (1) ZA908775B (el)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69228738D1 (de) * 1991-12-06 1999-04-29 Glaxo Group Ltd Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten
AU4931693A (en) * 1992-09-29 1994-04-26 Mcneil-Ppc, Inc. Ibuprofen-h2 antagonist combinations
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
US5648355A (en) * 1994-02-09 1997-07-15 Kos Pharmaceutical, Inc. Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
ZA975444B (en) * 1996-06-20 1998-12-21 Mcneil Ppc Inc Acetaminophen and meclizine hydrochloride analgesics
WO1998058637A1 (en) * 1996-06-20 1998-12-30 Mcneil-Ppc Acetaminophen and diphenhydramine analgesics
DE19801811B4 (de) * 1998-01-19 2004-12-23 Stada Arzneimittel Ag Pharmazeutische Zubereitung zur oralen Verabreichung
US7906153B2 (en) 1998-04-08 2011-03-15 Theta Biomedical Consulting & Development Co., Inc. Anti-inflammatory compositions for treating multiple sclerosis
US20050220909A1 (en) 2004-03-30 2005-10-06 Theoharides Theoharis C Composition for protection against superficial vasodilator flush syndrome
US7799766B2 (en) 1998-04-08 2010-09-21 Theta Biomedical Consulting & Development Co., Inc. Composition for treating hormonally-dependent cancers
GB9911017D0 (en) * 1999-05-13 1999-07-14 Zeneca Ltd Pharmaceutical compositions
IL145220A0 (en) * 1999-05-20 2002-06-30 Par Pharmaceutical Inc Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
WO2000074784A1 (en) * 1999-06-09 2000-12-14 Eli Lilly And Company Combination for treating weight gain associated with antipsychotic use comprising an atypical antipsychotic and an h2 antagonist
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SK10982003A3 (sk) * 2001-03-08 2004-02-03 Astrazeneca Ab Nové použitie
EP2260837A1 (en) 2001-06-01 2010-12-15 Pozen, Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US20040121004A1 (en) * 2002-12-20 2004-06-24 Rajneesh Taneja Dosage forms containing a PPI, NSAID, and buffer
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
US7923043B2 (en) 2004-03-30 2011-04-12 Theta Biomedical Consulting & Development Co., Inc. Method for protecting humans against superficial vasodilator flush syndrome
US7776873B2 (en) * 2005-12-01 2010-08-17 Yuhan Corporation Method for treating damage to gastric mucosa
CA2956278C (en) * 2008-01-04 2022-03-01 Schabar Research Associates Llc Unit oral dose compositions composed of ibuprofen and famotidine and applications thereof
CA2736547C (en) 2008-09-09 2016-11-01 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
KR20120030106A (ko) 2009-06-25 2012-03-27 아스트라제네카 아베 Ｎｓａｉｄ-연관된 궤양의 발생 위험이 있는 환자의 치료 방법
US9050275B2 (en) 2009-08-03 2015-06-09 Theta Biomedical Consulting & Development Co., Inc. Methods of screening for and treating autism spectrum disorders and compositions for same
US9176146B2 (en) 2009-08-03 2015-11-03 Theta Biomedical Consulting & Development Co., Inc. Methods of treating autism spectrum disorders and compositions for same
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
CA3159988C (en) 2020-07-15 2023-09-19 Bernard Schachtel Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn
US11324727B2 (en) 2020-07-15 2022-05-10 Schabar Research Associates, Llc Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105193A (en) * 1981-09-04 1983-03-23 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
WO1985003443A1 (en) * 1984-02-08 1985-08-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757060A (en) * 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105193A (en) * 1981-09-04 1983-03-23 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
WO1985003443A1 (en) * 1984-02-08 1985-08-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
UNLISTED DRUGS, vol. 20, no. 11, November 1968, page 167, Chatnam, New Jersey, US *

Also Published As

Publication number Publication date
EP0426479A1 (en) 1991-05-08
CA2028746C (en) 1995-12-26
GR1002097B (en) 1995-12-28
NZ235877A (en) 1992-09-25
PT95753A (pt) 1991-09-30
DE69006684D1 (de) 1994-03-24
KR910009254A (ko) 1991-06-28
ATE101515T1 (de) 1994-03-15
IN171746B (el) 1992-12-26
IE64953B1 (en) 1995-09-20
AU646230B2 (en) 1994-02-17
CA2028746A1 (en) 1991-05-03
EP0426479B1 (en) 1994-02-16
JPH03206052A (ja) 1991-09-09
AU6568990A (en) 1991-05-09
IE903946A1 (en) 1991-05-08
ZA908775B (en) 1992-07-29
DE69006684T2 (de) 1994-06-09
ES2057439T3 (es) 1994-10-16

Similar Documents

Publication Publication Date Title
GR1002097B (en) A process for providing a composition an analgesic in combination with a h1 or h2 receptor blocker proto n pump ihibitor or combination thereof
IL76932A (en) Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
GEP20002013B (en) Therapeutical Means
NO924169L (no) Preparat omfattende et tramadolmateriale og et ikke-stereoid antiinflammatorisk legemiddel
DK1024815T3 (da) Farmaceutisk sammensætning til oral administrering af molekylært iod
BE901667A (fr) Composition analgesique et anti-inflammatoire a base de diphenhydramine, leur preparation et leur utilisation.
NO20053105D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
EP1003494A4 (en) (d) -METHADONE, NON-OPIOID ANALGESIC
ES8307494A1 (es) "un procedimiento para preparar una composicion farmaceutica que proporciona un efecto anti-inflamatorio y analgesico junto con un dano gastrico minimizado".
NO992468L (no) Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID
ATE240097T1 (de) Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten
EP0345883A3 (en) Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine
IL70407A (en) Synergistic analgesic pharmaceutical compositions in unit dosage form,comprising an analgesic agent and hydroxyzine
DK0911038T3 (da) Vandfri sammensætning omfattende lactulose
DE3879489D1 (de) Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie.
CA2090234A1 (en) Method for providing improved analgesic effect
ZA989356B (en) Pharmaceutical preparations
SE8504612D0 (sv) Analgetiska och antiinflammatoriska kompositioner innefattande difenhydramin och forfaranden for anvendning av dessa
IT8422445A0 (it) Composti antiinfiammatori ed analgesici, procedimento per laloro preparazione e relative composizioni farmaceutiche.
BR9908155A (pt) Composto, composição farmacêutica, uso do composto, e, processo para intensificar cognição em um sujeito sofrendo de cognição diminuìda
BG100965A (en) New therapeutical injection-type analgetic pharmaceutical composition containing nimesulid (4-nitro, 2-phenoxyphenylmetanesulphonamide) for intramuscular administration and method for its preparation
HUP9903183A2 (hu) Olanzapin alkalmazása fájdalomcsillapító hatású gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees